Optimal post-remission therapy for flow-cytometry minimal residual disease positive patients with acute myeloid leukemia

被引：0
|
作者：
Venditti, A. [1 ]
Buccisano, F. [1 ]
Maurillo, L. [1 ]
Del Principe, M. I. [1 ]
Del Poeta, G. [1 ]
Ottaviani, L. [1 ]
Sarlo, C. [1 ]
Ammatuna, E. [1 ]
Fraboni, D. [1 ]
Imo-Consalvo, M. [1 ]
Amadori, S. [1 ]
机构：
[1] Univ Roma Tor Vergata, Rome, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0486
引用
收藏
页码：180 / 180
页数：1
相关论文
共 50 条
  • [31] ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - DETECTION OF MINIMAL RESIDUAL DISEASE (MRD) AT FLOW-CYTOMETRY
    ORFAO, A
    CIUDAD, J
    LOPEZBERGES, MC
    LOPEZ, A
    VIDRIALES, B
    CABALLERO, MD
    VALVERDE, B
    GONZALEZ, M
    SANMIGUEL, JF
    LEUKEMIA & LYMPHOMA, 1994, 13 : 87 - 90
  • [32] FLOW-CYTOMETRY IN MINIMAL RESIDUAL DISEASE ASSESSMENT
    LAMY, B
    HERVE, P
    TISSOT, C
    PETERS, A
    PATHOLOGIE BIOLOGIE, 1988, 36 (01): : 29 - 36
  • [33] MULTIPARAMETER FLOW-CYTOMETRY (MFC) MONITORS RESIDUAL DISEASE (RD) DURING COMPLETE REMISSION (CR) OF ACUTE MYELOID-LEUKEMIA (AML)
    BAER, MR
    LO, CH
    MEANS, J
    SALZMAN, G
    FRANKEL, SR
    LAWRENCE, D
    MOORE, JO
    HERZIG, GP
    SCHIFFER, CA
    BLOOMFIELD, CD
    STEWART, CC
    BLOOD, 1994, 84 (10) : A307 - A307
  • [34] Minimal residual disease studies by flow cytometry in acute leukemia
    Campana, D
    Coustan-Smith, E
    ACTA HAEMATOLOGICA, 2004, 112 (1-2) : 8 - 15
  • [35] Detection of minimal residual disease in acute leukemia by flow cytometry
    Campana, D
    Coustan-Smith, E
    CYTOMETRY, 1999, 38 (04): : 139 - 152
  • [36] Post-remission clonal hematopoiesis; Practical implications for measurable residual disease assessment in acute myeloid leukemia (AML).
    Loghavi, Sanam
    Tanaka, Tomoyuki
    Furudate, Ken
    Wang, Sa A.
    Takahashi, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [37] The determination of leukemic phenotype and minimal residual disease in acute myeloid leukemia by using flow cytometry
    Topcuoglu, P.
    Dalva, K.
    Meric, S.
    Sahin, S.
    Arat, M.
    Beksac, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 19 - 19
  • [38] Comparative Assessment Of Minimal Residual Disease In Acute Myeloid Leukemia By Flow Cytometry and Molecular Genetics
    Kern, Wolfgang
    Rose, Dominic
    Haferlach, Claudia
    Haferlach, Torsten
    Schnittger, Susanne
    BLOOD, 2013, 122 (21)
  • [39] Predictive Value of Minimal Residual Disease: Analysis By Flow-Cytometry in Children with Relapsed Acute Lymphoblastic Leukemia
    Guitter, Myriam Ruth
    Rossi, Jorge Gabriel
    Sajaroff, Elisa
    Carrara, Carolina
    Silvia, Pizzi
    Staciuk, Raquel
    Lagomarsino, Eduardo
    Millan, Natalia
    Rubio, Patricia
    Alonso, Cristina Noemi
    Zubizarreta, Pedro
    Felice, Maria Sara
    BLOOD, 2015, 126 (23)
  • [40] Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in patients with acute myeloid leukemia.
    Kern, W
    Voskova, D
    Schnittger, S
    Schoch, C
    Hiddemann, W
    Haferlach, T
    BLOOD, 2003, 102 (11) : 100A - 100A
12345